17.38 USD
▼-0.80-4.40%
盘后 17.72 +1.96%
2026-09-15
市值
$1.06B
市盈率
—
EPS
-2.34
股息率
—
52 周区间
6.91 – 28.00
成交量
849.77K
Beta
—
目标价
50.13
52W 低 6.9152W 高 28.00
价格走势
公司简介
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.